Fluorine in PDB 4rzv: Crystal Structure of the Braf (R509H) Kinase Domain Monomer Bound to Vemurafenib
Enzymatic activity of Crystal Structure of the Braf (R509H) Kinase Domain Monomer Bound to Vemurafenib
All present enzymatic activity of Crystal Structure of the Braf (R509H) Kinase Domain Monomer Bound to Vemurafenib:
2.7.11.1;
Protein crystallography data
The structure of Crystal Structure of the Braf (R509H) Kinase Domain Monomer Bound to Vemurafenib, PDB code: 4rzv
was solved by
Y.Wu,
E.Gavathiotis,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
44.77 /
2.99
|
Space group
|
I 2 2 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
64.975,
71.698,
243.281,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
20.4 /
26.7
|
Other elements in 4rzv:
The structure of Crystal Structure of the Braf (R509H) Kinase Domain Monomer Bound to Vemurafenib also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Crystal Structure of the Braf (R509H) Kinase Domain Monomer Bound to Vemurafenib
(pdb code 4rzv). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 4 binding sites of Fluorine where determined in the
Crystal Structure of the Braf (R509H) Kinase Domain Monomer Bound to Vemurafenib, PDB code: 4rzv:
Jump to Fluorine binding site number:
1;
2;
3;
4;
Fluorine binding site 1 out
of 4 in 4rzv
Go back to
Fluorine Binding Sites List in 4rzv
Fluorine binding site 1 out
of 4 in the Crystal Structure of the Braf (R509H) Kinase Domain Monomer Bound to Vemurafenib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Crystal Structure of the Braf (R509H) Kinase Domain Monomer Bound to Vemurafenib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F801
b:49.2
occ:1.00
|
F25
|
A:032801
|
0.0
|
49.2
|
1.0
|
C24
|
A:032801
|
1.4
|
39.8
|
1.0
|
C23
|
A:032801
|
2.1
|
39.6
|
1.0
|
C18
|
A:032801
|
2.6
|
37.4
|
1.0
|
C17
|
A:032801
|
3.2
|
32.4
|
1.0
|
CB
|
A:ALA481
|
3.4
|
31.7
|
1.0
|
CG1
|
A:VAL471
|
3.4
|
36.6
|
1.0
|
C22
|
A:032801
|
3.5
|
35.0
|
1.0
|
C15
|
A:032801
|
3.6
|
22.7
|
1.0
|
C
|
A:ALA481
|
3.6
|
29.9
|
1.0
|
O
|
A:ALA481
|
3.6
|
29.9
|
1.0
|
N
|
A:LYS483
|
3.7
|
30.8
|
1.0
|
C16
|
A:032801
|
3.7
|
26.5
|
1.0
|
C20
|
A:032801
|
3.7
|
39.4
|
1.0
|
C
|
A:VAL482
|
3.7
|
29.6
|
1.0
|
OG1
|
A:THR529
|
3.8
|
38.4
|
1.0
|
N
|
A:VAL482
|
3.8
|
29.1
|
1.0
|
CB
|
A:LYS483
|
3.9
|
38.8
|
1.0
|
O19
|
A:032801
|
4.0
|
30.5
|
1.0
|
CB
|
A:VAL471
|
4.0
|
39.3
|
1.0
|
O
|
A:VAL482
|
4.1
|
30.4
|
1.0
|
C21
|
A:032801
|
4.1
|
33.1
|
1.0
|
CA
|
A:ALA481
|
4.1
|
30.7
|
1.0
|
CA
|
A:LYS483
|
4.2
|
35.4
|
1.0
|
CA
|
A:VAL482
|
4.2
|
28.9
|
1.0
|
O
|
A:ILE527
|
4.4
|
36.1
|
1.0
|
N14
|
A:032801
|
4.6
|
22.0
|
1.0
|
CA
|
A:VAL471
|
4.7
|
32.8
|
1.0
|
C05
|
A:032801
|
4.7
|
24.2
|
1.0
|
F26
|
A:032801
|
4.9
|
44.0
|
1.0
|
O
|
A:TYR472
|
5.0
|
28.5
|
1.0
|
CE
|
A:LYS483
|
5.0
|
47.7
|
1.0
|
|
Fluorine binding site 2 out
of 4 in 4rzv
Go back to
Fluorine Binding Sites List in 4rzv
Fluorine binding site 2 out
of 4 in the Crystal Structure of the Braf (R509H) Kinase Domain Monomer Bound to Vemurafenib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Crystal Structure of the Braf (R509H) Kinase Domain Monomer Bound to Vemurafenib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F801
b:44.0
occ:1.00
|
F26
|
A:032801
|
0.0
|
44.0
|
1.0
|
C20
|
A:032801
|
1.4
|
39.4
|
1.0
|
C18
|
A:032801
|
2.4
|
37.4
|
1.0
|
C21
|
A:032801
|
2.4
|
33.1
|
1.0
|
N27
|
A:032801
|
2.8
|
29.5
|
1.0
|
C17
|
A:032801
|
2.8
|
32.4
|
1.0
|
O19
|
A:032801
|
3.0
|
30.5
|
1.0
|
N
|
A:ASP594
|
3.2
|
30.5
|
1.0
|
CE2
|
A:PHE583
|
3.3
|
25.1
|
1.0
|
CA
|
A:GLY593
|
3.5
|
27.8
|
1.0
|
CZ
|
A:PHE583
|
3.6
|
26.0
|
1.0
|
CD2
|
A:LEU514
|
3.6
|
34.1
|
1.0
|
C24
|
A:032801
|
3.6
|
39.8
|
1.0
|
C22
|
A:032801
|
3.6
|
35.0
|
1.0
|
C
|
A:GLY593
|
3.7
|
29.7
|
1.0
|
C16
|
A:032801
|
3.8
|
26.5
|
1.0
|
C15
|
A:032801
|
4.0
|
22.7
|
1.0
|
CA
|
A:ASP594
|
4.1
|
36.8
|
1.0
|
C23
|
A:032801
|
4.1
|
39.6
|
1.0
|
CB
|
A:ASP594
|
4.3
|
43.6
|
1.0
|
CD2
|
A:PHE583
|
4.4
|
25.1
|
1.0
|
S28
|
A:032801
|
4.5
|
43.0
|
1.0
|
N
|
A:GLY593
|
4.6
|
29.4
|
1.0
|
NZ
|
A:LYS483
|
4.7
|
48.2
|
1.0
|
O
|
A:GLY593
|
4.8
|
34.0
|
1.0
|
CG
|
A:ASP594
|
4.8
|
55.2
|
1.0
|
CE1
|
A:PHE583
|
4.9
|
26.9
|
1.0
|
F25
|
A:032801
|
4.9
|
49.2
|
1.0
|
CE
|
A:LYS483
|
5.0
|
47.7
|
1.0
|
C05
|
A:032801
|
5.0
|
24.2
|
1.0
|
CG
|
A:LEU514
|
5.0
|
31.9
|
1.0
|
|
Fluorine binding site 3 out
of 4 in 4rzv
Go back to
Fluorine Binding Sites List in 4rzv
Fluorine binding site 3 out
of 4 in the Crystal Structure of the Braf (R509H) Kinase Domain Monomer Bound to Vemurafenib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Crystal Structure of the Braf (R509H) Kinase Domain Monomer Bound to Vemurafenib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F801
b:49.3
occ:1.00
|
F25
|
B:032801
|
0.0
|
49.3
|
1.0
|
C24
|
B:032801
|
1.4
|
41.9
|
1.0
|
C23
|
B:032801
|
2.1
|
41.1
|
1.0
|
C18
|
B:032801
|
2.6
|
41.1
|
1.0
|
C17
|
B:032801
|
3.2
|
38.9
|
1.0
|
C
|
B:ALA481
|
3.3
|
36.8
|
1.0
|
N
|
B:VAL482
|
3.4
|
35.0
|
1.0
|
O
|
B:ALA481
|
3.4
|
36.0
|
1.0
|
CB
|
B:ALA481
|
3.4
|
37.0
|
1.0
|
C22
|
B:032801
|
3.5
|
42.5
|
1.0
|
C
|
B:VAL482
|
3.5
|
40.8
|
1.0
|
N
|
B:LYS483
|
3.5
|
40.7
|
1.0
|
OG1
|
B:THR529
|
3.6
|
41.0
|
1.0
|
C15
|
B:032801
|
3.6
|
34.7
|
1.0
|
CG1
|
B:VAL471
|
3.7
|
41.5
|
1.0
|
C16
|
B:032801
|
3.7
|
39.0
|
1.0
|
CA
|
B:VAL482
|
3.7
|
34.6
|
1.0
|
C20
|
B:032801
|
3.7
|
49.1
|
1.0
|
O
|
B:VAL482
|
4.0
|
39.0
|
1.0
|
O19
|
B:032801
|
4.0
|
46.4
|
1.0
|
CA
|
B:ALA481
|
4.0
|
38.0
|
1.0
|
CB
|
B:LYS483
|
4.1
|
41.1
|
1.0
|
C21
|
B:032801
|
4.1
|
45.4
|
1.0
|
O
|
B:ILE527
|
4.1
|
37.1
|
1.0
|
CA
|
B:LYS483
|
4.2
|
49.0
|
1.0
|
CG2
|
B:VAL471
|
4.4
|
39.5
|
1.0
|
CB
|
B:VAL471
|
4.5
|
40.4
|
1.0
|
N14
|
B:032801
|
4.6
|
35.4
|
1.0
|
C05
|
B:032801
|
4.7
|
41.3
|
1.0
|
CB
|
B:THR529
|
4.8
|
42.1
|
1.0
|
O
|
B:TYR472
|
4.9
|
49.4
|
1.0
|
CG2
|
B:THR529
|
4.9
|
38.9
|
1.0
|
N
|
B:THR529
|
4.9
|
39.6
|
1.0
|
F26
|
B:032801
|
4.9
|
51.9
|
1.0
|
|
Fluorine binding site 4 out
of 4 in 4rzv
Go back to
Fluorine Binding Sites List in 4rzv
Fluorine binding site 4 out
of 4 in the Crystal Structure of the Braf (R509H) Kinase Domain Monomer Bound to Vemurafenib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Crystal Structure of the Braf (R509H) Kinase Domain Monomer Bound to Vemurafenib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F801
b:51.9
occ:1.00
|
F26
|
B:032801
|
0.0
|
51.9
|
1.0
|
C20
|
B:032801
|
1.4
|
49.1
|
1.0
|
C21
|
B:032801
|
2.4
|
45.4
|
1.0
|
C18
|
B:032801
|
2.4
|
41.1
|
1.0
|
N27
|
B:032801
|
2.8
|
44.5
|
1.0
|
C17
|
B:032801
|
2.8
|
38.9
|
1.0
|
O19
|
B:032801
|
3.1
|
46.4
|
1.0
|
CD2
|
B:LEU514
|
3.3
|
30.4
|
1.0
|
CE2
|
B:PHE583
|
3.4
|
37.3
|
1.0
|
OD1
|
B:ASP594
|
3.5
|
70.1
|
1.0
|
N
|
B:ASP594
|
3.5
|
36.0
|
1.0
|
CA
|
B:GLY593
|
3.6
|
34.0
|
1.0
|
C22
|
B:032801
|
3.6
|
42.5
|
1.0
|
C24
|
B:032801
|
3.6
|
41.9
|
1.0
|
CZ
|
B:PHE583
|
3.7
|
39.0
|
1.0
|
C16
|
B:032801
|
3.8
|
39.0
|
1.0
|
C
|
B:GLY593
|
3.9
|
33.7
|
1.0
|
C15
|
B:032801
|
4.1
|
34.7
|
1.0
|
C23
|
B:032801
|
4.1
|
41.1
|
1.0
|
CG
|
B:ASP594
|
4.1
|
66.6
|
1.0
|
S28
|
B:032801
|
4.5
|
30.6
|
1.0
|
CD2
|
B:PHE583
|
4.5
|
36.6
|
1.0
|
CA
|
B:ASP594
|
4.6
|
43.8
|
1.0
|
NZ
|
B:LYS483
|
4.7
|
41.6
|
1.0
|
N
|
B:GLY593
|
4.7
|
31.9
|
1.0
|
OD2
|
B:ASP594
|
4.8
|
71.9
|
1.0
|
CG
|
B:LEU514
|
4.8
|
36.8
|
1.0
|
CB
|
B:ASP594
|
4.8
|
53.8
|
1.0
|
CE
|
B:LYS483
|
4.9
|
42.4
|
1.0
|
F25
|
B:032801
|
4.9
|
49.3
|
1.0
|
C05
|
B:032801
|
5.0
|
41.3
|
1.0
|
|
Reference:
Z.Karoulia,
Y.Wu,
T.A.Ahmed,
X.Qisheng,
J.Bollard,
C.Krepler,
X.Wu,
C.Zhang,
G.Bollag,
M.Herlym,
J.A.Fagin,
A.Lujambio,
E.Gavathiotis,
P.I.Poulikakos.
An Integrated Model of Raf Inhibitor Action Predicts Inhibitor Activity Against Oncogenic Braf Signaling Cancer Cell V. 30 1 2016.
ISSN: ISSN 1535-6108
Page generated: Thu Aug 1 05:41:58 2024
|